VTVT

vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin

08/11 08:00 am

vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin

05/19 09:00 am

7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - Synergistic Rise of Pumps, CGMs, and Ultra-rapid-acting Insulins in T1D Management

01/17 05:53 am

vTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes

06/24 04:05 pm

vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update

05/09 04:51 pm

vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference

03/01 09:00 am

S&P 500 Edges Lower; ADT Posts Upbeat Earnings

02/28 03:30 pm

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

02/28 03:02 pm

Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels

02/28 01:25 pm

vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund

02/28 09:00 am

Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket

01/24 09:14 am

Why United Airlines Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

01/23 08:55 am

Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

11/29 03:02 pm

Gold Rises 1%; Hibbett Shares Spike Higher

11/21 03:34 pm

Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

11/21 02:28 pm

Nasdaq Falls Over 100 Points; Burlington Shares Jump After Q3 Results

11/21 01:04 pm

vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update

11/09 05:30 pm

vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer

11/02 08:00 am

vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update

08/11 04:30 pm

vTv Therapeutics Partner Cantex Pharmaceuticals Licenses Exclusive Rights to Intellectual Property from Georgetown University for Azeliragon as a Potential Treatment for Cancer-Related Cognitive Decline

06/16 08:00 am

vTv Therapeutics Announces Issuance of U.S. Patent for Azeliragon as a Treatment of Glioblastoma to Cantex Pharmaceuticals

05/24 09:00 am

vTv Therapeutics Announces 2023 First Quarter Financial Results and Provides Corporate Update

05/11 04:15 pm

7 Hot Penny Stocks Under $1 To Watch This Week

03/07 03:23 pm

vTv Therapeutics Announces 2022 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

03/06 06:56 pm

Best Penny Stocks To Buy Under $1? 4 To Watch Now

03/06 01:19 pm

Elizabeth Keiley Selected as Executive Vice President and General Counsel of vTv Therapeutics

02/01 06:00 pm

vTv Therapeutics Appoints Biotech Industry Veteran Steven Tuch as Chief Financial Officer

12/13 09:15 am

VTv Therapeutics (VTVT) Reports Q3 Loss, Lags Revenue Estimates

11/10 07:45 pm

vTv Therapeutics Announces 2022 Third Quarter Financial Results and Provides Corporate Update

11/10 06:25 pm

Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Misses Revenue Estimates

11/02 05:35 pm

Is Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year?

09/22 09:40 am

This Diabetes Drug's 'Licensing Opportunity Is Underappreciated,' Analyst Says

08/19 12:42 pm

vTv Therapeutics Announces 2022 Second Quarter Financial Results and Provides Corporate Update

08/15 06:43 pm

vTv Therapeutics Announces Paul Sekhri as new President and Chief Executive Officer

07/27 07:00 am

vTv Therapeutics Announces Publication in Diabetes Obesity and Metabolism of Complete Results for the Mechanistic Study Assessing Effects of TTP399 on Ketones during Acute Insulin Withdrawal in Patients with Type 1 Diabetes

06/04 11:00 am

Hot Penny Stocks to Watch That Are Climbing Right Now 

06/01 03:38 pm

Benzinga's Brief On Trending Tickers: Salesforce, Mullen Automotive, Digital Turbine And More

06/01 09:32 am

vTv Therapeutics Announces Investment by and Entry into Collaboration and License Agreement with affiliates of G42 Healthcare

06/01 06:54 am

vTv Therapeutics Announces 2022 First Quarter Financial Results and Provides Corporate Update

05/12 07:45 am

Regeneron (REGN), Sanofi Get Priority Review for Dupixent sBLA

04/04 10:22 am

Best Penny Stocks to Watch This Coming Week 

02/21 12:30 pm

Best Penny Stocks To Buy? 8 Low Float Stocks To Watch Right Now

02/18 11:32 am

Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022

02/18 11:06 am

vTv Therapeutics Shares Updated Corporate Presentation

01/13 09:30 am

Intellia (NTLA) Inks Deal With Kyverna for Autoimmune Diseases

01/06 02:43 pm

Genprex's (GNPX) Lead Cancer Drug Gets Second Fast Track Tag

01/04 01:27 pm

Apellis (APLS) Up More Than 40% in Past 3 Months: Here's Why

01/03 01:05 pm

Kodiak Sciences (KOD) Focuses on Developing Eye Candidate KSI-301

12/30 11:18 am

Palatin (PTN) Begins Phase III Study For Dry Eye Disease

12/29 11:18 am

ACADIA (ACAD) Up on Resubmission Plan for Nuplazid sNDA to FDA

12/21 12:29 pm